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Abstract
Introduction: The purpose of the study was to assess the results of operative treatment of patients with tertiary hyperparathyroidism 
(tHPT) after kidney transplantation.
Material and methods: The study included 30 patients in whom kidney transplantation was performed between 2006 and 2013, and in whom 
parathyroidectomy had to be performed at a later time because of tHPT. There were 17 (56.7%) women and 13 (43,3%) men in the group, aged 
18–64, mean 46.1 years. In order to locate the lesion before the operation, all patients had to undergo USG, and 14 had scintigraphy MIBI in 
addition. Serum levels of PTH, ionised calcium, and creatinine were determined together with glomerular filtration rate (GFR). The results of 
control tests were compared with those performed one day before parathyroidectomy (PTX) and three days after the operation.
Results: Among 30 patients, 19 (63.3%) underwent total resection of three parathyroid glands and 3/4 of the fourth. Two parathyroid glands 
were resected in eight (26.7%) patients, and one in the remaining three (10%) patients. Histopathological examination showed one parathyroid 
adenoma in six (20%) patients, and one parathyroid adenoma and hyperplasia of the remaining glands in one (3.3%) patient. Five (16.7%) 
patients had hyperplasia of two parathyroid glands whereas no changes were observed in two patients. On the other hand, hyperplasia of 
all glands was noted in 18 (60%) patients. Serum PTH level was significantly lower compared to the level before operation (p < 0.001), being 
5.5–58.5 pg/mL, on day 3 postoperatively. Differences in the levels of serum-ionised calcium were also significant (p < 0.0001) after eight months.
Conclusions:
1. Surgical resection of parathyroid glands is a management of choice in patients after kidney transplantation accompanied by hypercal-
caemia lasting longer than one year.
2. Resection of 3 3/4 parathyroid glands because of hyperplasia in patients with hyperparathyroidism after kidney transplantation enables 
restoration of normal calcium metabolism.
3. Moreover, resection of 3 3/4 parathyroid glands can allow avoidance of autotransplantation, which is necessary in cases of total resection 
of parathyroid glands. (Endokrynol Pol 2015; 66 (5): 422–427)
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Streszczenie
Wstęp: Celem pracy była ocena wyników operacyjnego leczenia chorych z trzeciorzędową nadczynnością przytarczyc (tHPT) po 
przeszcze pieniu nerki. 
Materiał i metody: Badaniami objęto 30 chorych po przeszczepieniu nerki dokonanym w latach 2006–2013, u których w późniejszym 
czasie pojawiła się konieczność usunięcia przytarczyc z powodu tHPT. Było 17 (56,7%) kobiet oraz 13 (43,3%) mężczyzn w wieku 18–64 lat, 
śr. 46,1 lat. W celu lokalizacji zmienionych przytarczyc u wszystkich chorych wykonano przedoperacyjne badanie USG, a u 14 również 
scyntygrafię MIBI. Oznaczano u nich stężenie PTH w surowicy, wapnia zjonizowanego, kreatyniny oraz wskaźnik przesączania 
kłębuszkowego (GFR). Wyniki badań kontrolnych porównano z badaniami wykonanymi dobę przed parathyreoidektomią (PTX) oraz 
trzy dni po wykonaniu operacji.
Wyniki: Spośród 30 chorych u 19 (63,3%) dokonano wycięcia całkowitego trzech przytarczyc oraz 3/4 czwartej. U ośmiu (26,7%) chorych 
z kolei usunięto dwie zmienione przytarczyce, zaś u pozostałych trzech (10%) jedną. W badaniach histopatologicznych u sześciu (20%) 
chorych stwierdzono obecność gruczolaka jednej przytarczycy, u jednego (3,3%) zaś rozpoznano gruczolaka jednej przytarczycy, 
w pozostałych obserwując rozrost. U pięciu (16,7%) chorych rozpoznano rozrost dwóch przytarczyc, zaś dwie pozostawały niezmienione. 
Natomiast u 18 (60%) operowanych rozpoznano rozrost wszystkich przytarczyc. W trzeciej dobie po operacji usunięcia przytarczyc pomiar 
stężenia PTH w surowicy chorych ulegał ustabilizowaniu, obniżając się znamiennie w zakresie 5.5–58.5 pg/ml w porównaniu z okresem 
sprzed operacji (p < 0,001). Również po ośmiu miesiącach różnice te miały charakter znamienny (p < 0,0001).
Wnioski: 
1. Chirurgiczne wycięcie przytarczyc stanowi postępowanie z wyboru u chorych po przeszczepieniu nerki z hiperkalcemią trwającą 
ponad rok.
2. Wycięcie 3 i 3/4 przytarczycy z powodu ich rozrostu u chorych z nadczynnością przytarczyc po przeszczepie nerki, pozwala u leczonych 
na przywrócenie prawidłowej gospodarki wapniowej.
3. Wycięcie 3 i 3/4 gruczołu może pozwolić też na uniknięcie potrzeby dokonywania autotransplantacji jak to ma miejsce w przypadku 
całkowitego usunięcia przytarczyc. (Endokrynol Pol 2015; 66 (5): 422–427)
Słowa kluczowe: trzeciorzędową nadczynnością przytarczyc; parathyreoidektomia
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Introduction
Tertiary hyperparathyroidism (tHPT) is usually defined 
as excessive persistent secretion of PTH following 
kidney transplantation in patients with secondary hy-
perparathyroidism and in dialysis patients [1, 2]. Most 
patients receive normal function of their kidney after 
transplantation, but about 1–5.6% will have to undergo 
and operation for tHPT [3]. Still existing hyperparathy-
roidism may lead to production of stones within the 
transplanted kidney followed by disturbances in the 
transplant function, osteopaenia, pathological fractures, 
and finally mental disorders [4].
A management of choice in patients with tHPT 
after kidney transplantation is operative treatment. 
Although calcimimetic cinacalcet is fairly effective, 
its therapeutic effect is strictly confined to the period 
of its usage [5].
Indications for operation because of tHPT seem 
therefore to include:
 — no availability of successful medical treatment for 
more than 12 months;
 — hypercalcaemia > 3 mmol/L;
 — increasing osteoporosis and pathological fractures;
 — disturbances in the transplanted kidney function 
and signs of calculosis [6, 7].
The purpose of the study was to evaluate the late 
results of operative treatment used for patients with 
tertiary hyperparathyroidism following kidney trans-
plantation.
Material and methods
The study included 30 patients who underwent 
kidney transplantation between 2006 and 2013 and 
necessary resection of parathyroid glands at a later 
time because of tHPT. There were 17 (56.7%) women 
and 13 (43.3%) men aged 18–64, mean 46.1 years. 
Kidney failure was caused by glomerulonephritis 
in 22 (73.3%) patients, pyelonephritis in two (6.7%), 
congenital polycystic kidney disease in three (10%), 
and diabetic complications in another three. Dura-
tion of haemodialysis until kidney transplantation 
was 8–132, mean 54.3 months, and mean time from 
the transplantation to the resection of parathyroid 
glands was 49.2 months (3–180 months).
In order to locate the lesions before the operation, 
all patients received USG, and 14 of them scintigraphy 
MIBI in addition. At the operation time all patients had 
a kidney transplant and were receiving immunosup-
pressants.
Follow-up examinations were performed after 
a minimum of eight months from parathyroidectomy 
(PTX). Physical examinations were followed by testing 
serum level of PTH, levels of ionised calcium and cre-
atinine together with glomerular filtration rate (GFR) 
in MDRD formula. These examinations were compared 
with those performed one day before PTX and three 
days after the operation.
Statistical analysis was performed basing on 
STATISTICA data analysis software system v. 10 
(StatSoft Inc. 2011). Shapiro-Wilk test was used for 
sample distribution to compare time series among 
the groups, and ANOVA for repeated measures with 
post-hoc Bonferroni test. Upon sample distribution, 
kidney activity was assessed by Student’s t test for 
related values. The data were presented as means 
and standard deviations with reference to absolute 
numbers and percentages. The values of p < 0.05 
were considered as significant.
Results
Clinical symptoms in patients with tertiary hyperpar-
athyroidism referred to operative treatment are shown 
in the table (Table I).
One (3.3%) patient received PTX after three months 
from kidney transplantation as he was under threat 
of parathyroid crisis in spite of using calcimimetics. 
Another nine (30%) patients were operated between 
12 and 24 months from the transplantation, and eight 
(26.7%) between 24 and 36 months. The remaining 
12 (40%) patients received PTX between 48 and 180 
months from the kidney transplantation.
In the group of 30 patients, three and 3/4 parathyroid 
glands were resected in 19 (63.3%), two were resected in 
eight (26.7%), and one in the remaining three (10%). In 
these last 11 patients biopsy specimens were taken from 
the remaining parathyroid glands for intra-operative 
histopathological examinations. No pathology was 
shown in the results.
Histopathological examinations showed one para-
thyroid adenoma and normal glands in six (20%) pa-
tients, and one parathyroid adenoma and hyperplasia 
of the remaining glands in one (3.3%). Hyperplasia of 
two parathyroid glands and two normal were found 
in five (16.7%) patients. Hyperplasia of all parathyroid 
glands was found in 18 (60%) patients.
During the follow-up, four (13.3%) patients died, 
after 14, 15, 17, and 26 months from the operation. One 
of them had cerebral haemorrhage, and three died from 
progressive circulatory failure.
In general, the mean level of serum PTH was 
679.8 (n = 15–65) pg/mL (135.8–3291 pg/mL) before 
the operation, while the mean level of ionised calcium 
was 1.5 (n = 1.12–1.27) mmol/L (0.97–1.73 mmol/L). 
Three (10%) patients showed serum-ionised calcium 
of 1.2 mmol/L (0.97, 1.02, 1.16) before PTX in spite of 
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high values of the parathormone (PTH) i.e. 3291, 1712, 
and 1309 pg/mL.
On day 3 after the operation, the level of serum 
PTH decreased remarkably compared with before 
the operation (p < 0.001) and ranged between 
5.5 and 58.5 pg/mL (Fig. 1). Only three (10%) patients 
showed higher PTH level, i.e. 78.5 and 621.8 pg/mL, 
respectively. Follow-up examinations, performed 
a minimum of eight months after PTX in 26 patients, 
showed normal values and ranged between 19.3 and 
55 pg/mL. The differences were significant relative 
to the examinations performed before the operation 
(p < 0.001). However, this level exceeded the upper 
limit of the range and was 87.5, 96, 68.4, and 114 pg/mL, 
respectively. Differences in the levels of serum ionised 
calcium after eight months were also significant as 
compared with the preoperative period (p < 0.0001) 
(Fig. 2). The level of ionised calcium in all patients, 
including the four who had an increased PTH level, 
did not exceed the reference limits and was 1.17, 1.2, 
1.24, and 1.29 mmol/L, respectively.
After a minimum of eight months from the opera-
tion, the differences in creatinine levels or GFR values 
were not significant relative to the preoperative period 
(p = 0.507; p = 0.353) (Fig. 3 and 4). However, it may 
be important to note that the value of GFR after PTX 
exceeded 50% only in nine patients.
Discussion
Chronic kidney failure can lead to retention phosphorus 
and disturbances in production of 1.25-hydroxyvitamin 
D. This will cause a decrease in serum calcium leading to 
strong and extended stimulation of parathyroid glands, 
resulting in secondary hyperparathyroidism (sHPT). 
Generally, most patients with sHPT lose their hypocal-
caemia gradually during the first year after successful 
transplantation because of normal PTH stimulation [8]. 
But patients with tHTP show normal function of the 
kidney after transplantation and no normal PTH secre-
tion, the latter becoming autonomic and nonspecific 
relative to the level of serum calcium [9].
The stage of tHPT seems to depend on sHPT severity 
before the transplantation and on the duration of dialy-
ses [10, 11]. Therapeutic management of tHPT remains 
a controversial issue. Currently, a well accepted opinion 
is that patients with persistent hypercalcaemia, if last-
ing longer than one year after kidney transplantation, 
should be considered as candidates for PTX [1, 5, 12, 13], 
whereas operative treatment in the first year after the 
transplantation should only be taken into account if no 
response to pharmacological treatment is obtained. This 
is confirmed by our patients, among whom only one 
received PTX after three months from the transplanta-
Table I. Characteristics of 30 patients operated between 2006 
and 2013 for tertiary hyperparathyroidism
Tabela I. Charakterystyka 30 pacjentów operowanych 
w latach 2006–2013 z powodu trzeciorzędowej nadczynności 
przytarczyc
Description No. of patients (%)
Sex
Women
Men
17 (56.7%)
13 (43.3%)
Age (years) 18–64. mean 46.1
Cause of kidney failure
Glomerulonephritis
Pyelonephritis 
Congenital polycystic kidney disease 
Diabetic complications
22 (73.3%)
2 (6.7%)
3 (10%)
3 (10%)
Symptoms before operation
Bone pains
Signs of depression 
Excessive sweating 
Significant weakness 
Calcifications in the transplanted kidney 
Signs of osteopenia 
Persistent itching of the skin 
Extraskeletal calcifications 
Myopathy
27 (90%)
12 (40%)
9 (30%)
8 (26.7%)
8 (26.7%)
6 (20%)
3 (10%)
2 (6.6%)
2 (6.6%)
Duration of dialyses before kidney 
transplantation (months)
8–132. mean 54.3
Length of time from kidney  
transplantation  
to PTX (months)
3–180. mean 49.2
Range of operation
Resection of 3 3/4 parathyroids
Resection of 2 parathyroid glands and 
collection of specimens from the rest
Resection of 1 parathyroid gland and 
collection of specimens from the rest
19 (63.3%)
8 (26.7%)
3 (10%)
Histopathological diagnosis
Hyperplasia of all glands 
Hyperplasia of 2 glands + 2 normal 
Adenoma on 1 gland + 3 normal 
Adenoma on 1 gland + hyperplasia  
of the rest
18 (60%)
5 (16.7%) 
6 (20%)
1 (3.3%)
Duration of follow-up after PTX  
(months)
6–87. mean 35
Alive 26 (86.8%)
Dead 4 (13.2%)
Causes of death
Cerebral haemorrhage 
Circulatory failure
1 (3.3%)
3 (10%)
PTX — parathyroidectomy
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tion because he was in threat of parathyroid crisis and 
had sharp pains.
Operative treatment for tHPT can consist of total 
PTX and autotransplantation, or subtotal PTX [1, 7, 8]. 
The latter is only suggested if one or two glands are 
enlarged (14,15). A consensus in this matter has not yet 
been reached. Contrary to earlier authors reporting that 
PTX has no harmful effect on the transplanted kidney, 
it is nowadays accepted that PTX may cause a dysfunc-
tion of the transplant [16]. In our Department we follow 
a rule that if an adenoma has been recognised, we 
only resect one parathyroid gland, taking specimens 
from the rest for histopathological examinations. If any 
doubts arise, another gland is resected, as was done 
in two of our patients, with good results. Undoubt-
edly a problem remains in recognising hyperplasia of 
two glands with no changes in the rest. In such situa-
tions we only decide to resect the hyperplastic glands 
(of course provided the histopathologist has no doubts 
as to the remaining glands).
On the other hand, if all parathyroid glands are 
found hyperplastic, we resect 3 3/4 glands as a rule. We 
believe that 1/4 of the gland is enough to reach thera-
peutic effect — proper control of calcium metabolism 
— and to avoid implanting the gland into the forearm 
or sterno-mastoid muscle as recommended by some 
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Figure 1. Level of PTH (pg/mL) before PTX; 3 days and minimum 
8 months after PTX 
Rycina 1. Stężenie PTH (pg/ml) przed PTX, oraz wczesnym 
i odległym okresie po PTX
Figure 2. Level of ionized calcium (mmol/L) before and; 3 days 
and minimum 8 months after PTX
Rycina 2. Stężenie wapnia zjonizowanego (mmol/l) przed i po 
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Figure 3. The values of glomerular filtration rate (ml/min/1.73 m2) 
using MDRD formula in patients before and after PTX
Rycina 3. Wartości wskaźnika przesączania kłębuszkowego 
(ml/min/1,73 m2) według MDRD u pacjentów przed i po PTX
Figure 4. The values of creatinine (mg/dL) in patients before and 
after PTX
Rycina 4. Stężenie kreatyniny (mg/dl) u pacjentów przed 
i po PTX
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authors in case of total PTX [2, 11, 14]. Our management 
of 16 surviving study patients suggested that leaving 
the gland portion in situ might give satisfactory results. 
Remote examinations only showed in two (12.5%) 
patients a very slight increase in PTH level to 68.4 and 
87.5 pg/mL. In these patients serum ionised calcium 
level was 1.29 and 1.17 mmol/L, respectively. However, 
among seven surviving patients after resection of two 
parathyroid glands, serum PTH level was found to in-
crease to 96 and 114 pg/mL in two (28.6%) and ionised 
calcium level to 1.2 and 1.24 mmol/L.
We would like to stress here that in case hyperpar-
athyroidism has been suspected, irrespective of the 
cause, we are definitely against performing preop-
erative biopsy of the gland for diagnostic purposes. 
We believe that biopsy procedure can easily damage 
the delicate capsule of the organ, no matter how cau-
tious or careful the approach taken. Consequently, an 
undesired dissemination and insertion of the para-
thyroid cells into adjacent tissues would take place 
leading to what is called parathyroidismus. Moreover, 
some adhesions are likely to develop around the 
gland, causing problems with its atraumatic prepara-
tion. Also, we avoid using mini-invasive techniques 
because our opinion is that classic parathyroidectomy 
causes a small problem for the patient allowing the 
collection of specimens from all glands, if necessary, 
and making the procedure quicker and easier, espe-
cially when intra-operative measurement of PTH 
concentration is required.
In this group of 37 patients, Schmidt observed an 
increase in the level of acute implant rejection reaction 
after PTX for tHPT [2, 17]. Lee reported a negative ef-
fect of subtotal PTX on transplanted kidney function in 
22 patients [18]. Garcia described persistent damage to 
kidney function after PTX in patients who showed an 
increase in serum creatinine level preoperatively [19]. 
PTH and calcium levels in all our patients who under-
went PTX during 54 months on average (23–142) were 
normal, and no disorders related to PTX were found 
with reference to the implant function.
Damage to implants is possibly connected with 
the operation method. Patients who underwent total 
resection of PTX accompanied by autotransplanta-
tion showed significant decrease in serum PTH and 
calcium levels, but a decrease in GFR was also noted. 
On the other hand, patients who had subtotal or re-
stricted PTX showed a smaller decrease in PTH and 
calcium levels, and a slow increase in GFR during 
three months after PTX, although the differences in 
GFR values were not significant. Schwarz [20] dem-
onstrated that changes in PTH levels are an important 
factor that influences kidney function. He observed a 
direct correlation between a decrease in PTH after the 
operation and creatinine clearance. Also, Schlosser 
demonstrated that surgical technique has a direct 
influence on postoperative transplant function. This 
was confirmed in Park’s study [2, 21].
Park’s examinations are restricted from the point 
of view of remote results. Results of all examinations 
indicate that PTX may cause regression of tHPT 
symptoms as the serum calcium level goes back to 
normal. However, kidney transplant must be con-
trolled for its efficiency before PTX because resection 
of parathyroid glands may be connected with a risk of 
damaging its function. Based on laboratory research 
it is assumed that subtotal PTH, instead of total PTH 
with autotransplantation (AT), helps to avoid the 
risk of damaging the transplant function in tHPT 
patients. Therefore, restricted PTX is recommended 
in selected patients where the lesion evidently refers 
to one or two glands [8, 9, 11]. Our study confirmed 
beneficial late results of subtotal PTX in patients with 
multiglandular hyperplasia. Leaving a fragment of 
one parathyroid gland untouched allows the avoid-
ance of AT procedure, maintaining correct function 
of the transplant, and providing correct calcium 
metabolism.
Conclusions
1. Surgical resection of parathyroid glands is a man-
agement of choice in patients after kidney trans-
plantation and with persistent, over one-year long 
hypercalcaemia.
2. Resection of 3 3/4 parathyroid glands for hyper-
plasia in patients with hyperparathyroidism, after 
kidney transplantation, allows calcium metabolism 
to return to normal.
3. Moreover, resection of 3 3/4 parathyroid glands can 
allow avoidance of autotransplantation, which is 
necessary in cases of total resection of parathyroid 
glands.
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